What is SkinVision?
SkinVision operates at the intersection of mobile health and medical diagnostics, offering a sophisticated application that utilizes AI to analyze skin lesions for potential malignancy. The platform is designed to empower users with personalized health path recommendations while maintaining rigorous clinical standards. By integrating oversight from dermatologists, the company ensures that its technology serves as a reliable tool for both patients and healthcare providers. With a user base exceeding 3 million, SkinVision has established a strong market position, effectively connecting consumers, medical professionals, and insurance entities to optimize skin health outcomes and reduce the long-term burden of skin-related pathologies.
How much funding has SkinVision raised?
SkinVision has raised a total of $11M across 2 funding rounds:
Unspecified
$3.4M
Unspecified
$7.6M
Unspecified (2015): $3.4M with participation from Personal Health Solutions Capital and LEO Pharma
Unspecified (2018): $7.6M led by LEO Pharma and PHS Fund
Key Investors in SkinVision
LEO Pharma
A global, research-based pharmaceutical company specializing in medical dermatology, LEO Pharma focuses on developing innovative treatments for skin conditions and advancing standards of care worldwide.
Personal Health Solutions Capital
An Amsterdam-based investment firm dedicated to the consumer health and well-being sector, focusing on science-based, technology-enabled solutions that improve quality of life.
PHS Fund
Undisclosed investor participating in the funding round.
What's next for SkinVision?
Looking ahead, the company is poised to leverage its recent capital injection to expand its clinical footprint and enhance its diagnostic accuracy. The strategic focus will likely center on deepening partnerships with global healthcare systems and insurance providers to integrate its AI-driven screening tools into standard preventative care workflows. As the digital health landscape matures, SkinVision is well-positioned to transition from a consumer-facing application to a foundational component of the global dermatology ecosystem, driving efficiency in early detection and personalized treatment planning.
See full SkinVision company page
